Literature DB >> 32298948

Whole-brain structural covariance network abnormality in first-episode and drug-naïve major depressive disorder.

Keita Watanabe1, Shingo Kakeda2, Asuka Katsuki3, Issei Ueda4, Atsuko Ikenouchi3, Reiji Yoshimura3, Yukunori Korogi4.   

Abstract

There has been a growing interest in the abnormality of networks across the brain in major depressive disorder (MDD). We aimed to investigate the structural covariance networks in patients with first-episode and drug-naïve MDD using structural imaging. A total of 77 patients with first-episode and drug-naïve MDD and 79 healthy subjects (HS) were recruited, from whom high-resolution T1-weighted images were analysed. Incident component analysis was used to calculate the brain networks based on grey matter volume covariance. There were significant differences in salience network, medial temporal lobe network, default mode network and central executive network between MDD and HS (p < 0.05). Further, the disturbance of medial temporal lobe network was significantly correlated with the severity of depressive symptoms (p < 0.05). In conclusion, we found a novel abnormality in the brain network in the medial temporal lobe primarily involving the hippocampus and parahippocampal gyrus in patients with first-episode and treatment-naïve MDD.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Year:  2020        PMID: 32298948     DOI: 10.1016/j.pscychresns.2020.111083

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  3 in total

1.  Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study.

Authors:  Naomichi Okamoto; Keita Watanabe; LeHoa Ngyuyen; Atsuko Ikenouchi; Taro Kishi; Nakao Iwata; Shingo Kakeda; Yukunori Korogi; Reiji Yoshimura
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-29       Impact factor: 2.570

2.  Large-scale structural network change correlates with clinical response to rTMS in depression.

Authors:  Daniel M Blumberger; Jonathan Downar; Sean M Nestor; Arsalan Mir-Moghtadaei; Fidel Vila-Rodriguez; Peter Giacobbe; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2022-02-02       Impact factor: 8.294

3.  Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression.

Authors:  Hirofumi Tesen; Keita Watanabe; Naomichi Okamoto; Atsuko Ikenouchi; Ryohei Igata; Yuki Konishi; Shingo Kakeda; Reiji Yoshimura
Journal:  Front Hum Neurosci       Date:  2022-01-03       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.